[HTML][HTML] Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis

…, J Breuer, AC Hayward, A Mavrodaris, BH Ridha… - Scientific reports, 2019 - nature.com
Interest is growing in the role of infectious agents in the pathogenesis of dementia, but current
evidence is limited. We conducted a systematic review and meta-analysis to investigate …

Neurosyphilis in patients with HIV

E Hobbs, JH Vera, M Marks, AW Barritt, BH Ridha… - Practical …, 2018 - pn.bmj.com
Syphilis is a resurgent sexually transmitted infection in the UK that is disproportionately
diagnosed in patients living with HIV, particularly in men who have sex with men. Syphilis …

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study

BH Ridha, J Barnes, JW Bartlett, A Godbolt… - The Lancet …, 2006 - thelancet.com
… Basil Ridha and colleagues' study 1 in this issue is an important addition to the research
of imaging in Alzheimer's disease. The study was done by a group that has pioneered the …

Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease

M Lehmann, SJ Crutch, GR Ridgway, BH Ridha… - Neurobiology of …, 2011 - Elsevier
A significant minority of Alzheimer's disease patients present with posterior cortical atrophy (PCA).
PCA is characterized by visuospatial and visuoperceptual deficits, and relatively …

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2

HH Klunemann, BH Ridha, L Magy, JR Wherrett… - Neurology, 2005 - AAN Enterprises
Background: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
(PLOSL), or Nasu-Hakola disease, is a presenile dementia associated with loss of myelin…

Volumetric MRI and cognitive measures in Alzheimer disease: comparison of markers of progression

BH Ridha, VM Anderson, J Barnes, RG Boyes… - Journal of …, 2008 - Springer
Background Both cognitive tests and MRI-based measures have been suggested as outcomes
in trials assessing disease-modifying therapies in Alzheimer's disease (AD). Objective To …

[HTML][HTML] Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

…, R Lawrence, B McFarlane, G Tadros, BH Ridha… - Trials, 2019 - Springer
Background Liraglutide is a glucagon-like peptide-1 (GLP-1) analogue currently approved
for type 2 diabetes and obesity. Preclinical evidence in transgenic models of Alzheimer’s …

Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy

…, RW Paterson, CF Slattery, AJM Foulkes, BH Ridha… - Brain, 2019 - academic.oup.com
Posterior cortical atrophy is a clinico-radiological syndrome characterized by progressive
decline in visual processing and atrophy of posterior brain regions. With the majority of cases …

Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine

BH Ridha, KA Josephs, MN Rossor - Neurology, 2005 - AAN Enterprises
Three patients with probable dementia with Lewy bodies (DLB) experienced worsening
delusions and visual hallucinations as a result of memantine therapy. Significant resolution …

[HTML][HTML] Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?

…, B McFarlane, G Tadros, BH Ridha… - Alzheimer's research & …, 2021 - Springer
Background Type 2 diabetes is a risk factor for Alzheimer’s disease (AD), and AD brain
shows impaired insulin signalling. The role of peripheral insulin resistance on AD …